Breast Cancer Trial, Recruiting NCT06548919 Sponsor: SciClone Pharmaceuticals Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06548919
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with breast cancer (confirmed by a tissue or cell sample) that has either spread to nearby areas and cannot be removed by surgery or treated with high-dose radiotherapy, or has spread to other parts of the body and is not suitable for intensive treatment.
  • You are a woman aged 18 or older.
  • You are postmenopausal, meaning you meet at least one of the following: you have had your ovaries removed; you are aged 60 or older; you are between 41 and 60 years old and have not had a period for at least 1 year; or you are under 60 and are receiving treatment to stop your ovaries from working.
  • Your breast cancer has been tested and confirmed to be ER-positive (driven by oestrogen), HER2-negative, and has a specific gene change called an ESR1 mutation.
  • Your cancer has already been treated with at least one hormone-based (endocrine) therapy before joining the trial, whether taken alone or in combination with another treatment.
  • Your major organs (such as liver and kidneys) are functioning normally, as assessed by the trial doctor.

Who may not be able to join:

  • You are currently pregnant or breastfeeding.
  • You have known difficulty swallowing tablets or capsules, a condition that affects how your body absorbs oral medications, or a known allergy to the trial drug or any of its ingredients.
  • There are other medical or personal reasons that the trial doctor believes make it unsuitable for you to take part (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-15216717343

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
SciClone Pharmaceuticals
Registry
ClinicalTrials.gov
Start date
8 August 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

PFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov